Transamerica Financial Advisors’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$36.1K Sell
193
-28,808
-99% -$5.3M ﹤0.01% 751
2026
Q1
$5.47M Buy
29,001
+1,298
+5% +$273K 0.47% 56
2025
Q4
$5.51M Buy
27,703
+27,663
+69,158% +$5.59M 0.46% 58
2025
Q3
$8.12K Buy
+40
New +$7.1K ﹤0.01% 767
2014
Q2
– Sell
-585
Closed -$26K – 718
2014
Q1
$26K Hold
585
– – ﹤0.01% 389
2013
Q4
$25K Hold
585
– – ﹤0.01% 396
2013
Q3
$25K Buy
+585
New +$24.5K ﹤0.01% 374

Other funds holding THC

Transamerica Financial Advisors's THC Position: Q2 2026 in Review

Transamerica Financial Advisors reduced its Tenet Healthcare (THC) stake by 99% in Q2 2026, selling an estimated $5.3M and leaving 193 shares worth $36.1K. The position accounts for ﹤0.01% of the portfolio, ranked #751.

Transamerica Financial Advisors first reported a position in THC in Q3 2013 and has held it in 7 quarters since. The position peaked at $5.51M in Q4 2025. 681 funds tracked by Wall St. Rank hold THC as of Q2 2026.

  • Transamerica Financial Advisors held 193 shares of Tenet Healthcare worth $36.1K as of Q2 2026.
  • Transamerica Financial Advisors sold 28,808 Tenet Healthcare shares in Q2 2026, an estimated $5.3M.
  • Tenet Healthcare made up ﹤0.01% of Transamerica Financial Advisors's portfolio in Q2 2026, its #751 holding.
  • Transamerica Financial Advisors first reported a position in Tenet Healthcare in Q3 2013 and has held it in 7 quarters since.
  • Transamerica Financial Advisors's Tenet Healthcare position peaked at $5.51M in Q4 2025.
  • 681 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2026.

Based on Transamerica Financial Advisors's 13F filing for Q2 2026, filed 17 Aug 2026.